Prognostic value of cyclin A2 and B1 expression in lung carcinoids

• Published in: Pathology Vol. 51; no. 5; pp. 481 - 486
• Main Authors: Brcic, Luka, Heidinger, Martin, Sever, Anita Zenko, Zacharias, Martin, Jakopovic, Marko, Fediuk, Melanie, Maier, Alfred, Quehenberger, Franz, Seiwerth, Sven, Popper, Helmut
• Format: Journal Article
• Language: English
• Published: England Elsevier B.V 01.08.2019
• Subjects: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor - analysis; Carcinoid; Carcinoid Tumor - mortality; Carcinoid Tumor - pathology; cyclin; Cyclin A2 - biosynthesis; Cyclin B1 - biosynthesis; Female; Humans; Ki-67; lung; Lung Neoplasms - mortality; Lung Neoplasms - pathology; Male; Middle Aged; mitosis; Prognosis; Progression-Free Survival; Young Adult; lung; Ki-67; Carcinoid; cyclin; mitosis
• ISSN: 0031-3025; 1465-3931
• DOI: 10.1016/j.pathol.2019.03.011

Carcinoid classification in the lung is still based on morphological criteria. Although there are many studies investigating the role of Ki-67 proliferation index in the classification of lung neuroendocrine tumours, it is still not used in routine diagnostics. Interestingly, cyclins, which have a crucial role in controlling the cell cycle, have not been thoroughly studied in lung neuroendocrine tumours. The aim of our study was to investigate the correlation of cyclin A2 and B1 expression with prognosis, Ki-67 proliferation index, and carcinoid morphology. A cohort of 134 resected typical and atypical carcinoids was stained with antibodies against Ki-67, cyclin A2 and B1. The positive nuclear reaction was assessed in hot spot areas and expressed as the percentage of tumour cells. Univariate analyses found the highest relative hazard between low and high cyclin A2 expression both with respect to overall survival [hazard ratio (HR)=16; 95% confidence interval (CI) 4.8–51; p=0.0000054], and relapse (HR=8; 95% CI 3.1–21; p=0.00002). In multivariate analysis for overall survival cyclin A2 (HR=10; 95% CI 2.5–>100; p=0.0082) and B1 (HR=6.5; 95% CI 1.5–35; p=0.02) remained significant when adjusted for other risk factors, whereas Ki-67 was no longer significant (HR=0.64; 95% CI 0.003–5.5; p=0.65). This suggests that Ki-67 is closer to conventional risk factors for survival than cyclin A2 and B1. Furthermore, the analysis revealed 4 mitoses per 2 mm2 as a more powerful prognostic cut-off than currently accepted 2 mitoses. We have clearly demonstrated that application of cyclin A2 and cyclin B1 might bring additional value regarding the overall and progression-free survival of patients with carcinoids of the lung.